MESS — Mangled Extremity Severity Score Calculator

About

The MESS (Mangled Extremity Severity Score) was developed by Johansen et al. in 1990 and published in the Journal of Trauma. It was designed to provide an objective, reproducible assessment of limb injury severity and to predict the probability of amputation. The score combines four components: skeletal/soft-tissue injury severity, limb ischemia (with doubling for ischemia >6 hours), hemodynamic stability (shock), and patient age. In the original validation study, all patients with a MESS score ≥7 ultimately required amputation (100% positive predictive value), while no patient with a score <7 required amputation (100% negative predictive value). The score has been validated in multiple civilian trauma centers and military settings, although recent advances in revascularization techniques and damage control orthopedics have challenged the absolute threshold. Current clinical practice uses MESS as one component of a comprehensive decision-making algorithm that includes patient preferences, comorbidities, functional demands, and institutional capabilities. Evidence level: Grade B, supported by multiple retrospective and prospective validation studies.

Formula

MESS = Skeletal/Soft-Tissue Injury (1-4) + Limb Ischemia (1-3, doubled if >6 hours) + Shock (0-3) + Age (0-2)

The MESS score is calculated by summing four weighted components: (1) Skeletal/soft-tissue injury: 1 point for low-energy injuries (stab wound, simple GSW), 2 points for medium-energy injuries (dislocation, open fracture), 3 points for high-energy crush injuries, and 4 points for very high-energy massive crush injuries. (2) Limb ischemia: 1 point for reduced pulses but perfused limb, 2 points for pulseless with paraesthesia, and 3 points for cool, paralyzed, numb limb. The ischemia score is DOUBLED if ischemia duration exceeds 6 hours. (3) Shock: 0 points for normotensive (SBP >90), 1 point for transient hypotension (responsive to fluids), 2 points for persistent hypotension (SBP <90 despite fluids), and 3 points for persistent hypotension with oliguria. (4) Age: 0 points for age <30, 1 point for age 30-50, and 2 points for age >50. The total score ranges from 0 to 14.

Score Interpretation

The MESS score addresses one of the most difficult decisions in trauma surgery: whether to attempt limb salvage or proceed with amputation in severe lower extremity trauma. The decision carries profound implications for patient survival, functional outcome, quality of life, and healthcare resource utilization. Limb salvage procedures are associated with multiple surgeries, prolonged hospitalization, high complication rates (infection, non-union, chronic pain), and uncertain functional recovery. Conversely, amputation offers definitive treatment but carries permanent disability. The original MESS validation by Johansen et al. (1990) demonstrated 100% sensitivity and specificity at a threshold of 7 in a study of 26 patients. Subsequent larger studies have shown more nuanced results: (1) A meta-analysis by Schirò et al. (2020) including 1,478 patients found pooled sensitivity of 81.3% and specificity of 78.9% at MESS ≥7 threshold. (2) The LEAP study (Bosse et al., 2001) found no significant difference in functional outcomes between salvage and amputation at 2-year follow-up, though amputation patients trended toward worse outcomes on Sickness Impact Profile. (3) Military experience from Iraq and Afghanistan showed MESS ≥7 had 59% sensitivity and 93% specificity for amputation (Brown et al., 2009). Current guidelines recommend using MESS as part of a comprehensive assessment including: patient hemodynamic status, comorbid conditions, functional demands, Gustilo-Anderson fracture classification, vascular injury location and extent, soft tissue and nerve injury assessment, and institutional capabilities. The Lower Extremity Assessment Project (LEAP) identified additional factors predictive of amputation: plantar sensation loss, crush mechanism, lack of pulse on admission, and warm ischemia time >6 hours. MESS should be applied early in the resuscitation phase and serially reassessed after initial interventions.

Reference Ranges